Deshpande Milind

Avg. Two Year Performance

(29%) Avg. Purchase Return
(13%) Compound
31% Avg. Sale Return
14% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return2%(2%)10%(26%)(29%)
Purchase Success Rate1 of 10 of 11 of 10 of 10 of 1
Average Sale Return(3%)(2%)10%25%31%
Sale Success Rate3 of 64 of 65 of 66 of 64 of 6
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 2.5K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 51.45K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--